Kali Metals Limited (ASX:KM1) Expands Pilbara Gold Tenure
Kali Metals Limited (ASX:KM1) acquires new tenements, expanding its Marble Bar Project and enhancing gold exploration in Pilbara.
Firebird Metals Limited (ASX:FRB) Granted Mining Lease for Oakover Project
Firebird Metals (ASX:FRB) secures Mining Lease ML52/1086 for Oakover Project, advancing its strategy in manganese-based battery materials.
Dropsuite Limited (ASX:DSE) Faces Application to Takeovers Panel
Harvest Lane Asset Management files application with the Takeovers Panel concerning Dropsuite Limited (ASX:DSE)’s shareholder activities amid a proposed acquisition.
Nimy Resources (ASX:NIM) Signs MoU with Curtin University
Nimy Resources (ASX:NIM) partners with Curtin University to advance gallium research, enhancing its position in the critical minerals market.
Adelong Gold Limited (ASX:ADG) Identifies High-Grade Antimony-Gold Potential at Heyfield Reef Prospect
Adelong Gold (ASX:ADG) identifies significant antimony-gold potential at Heyfield Reef Prospect, Apollo Project VIC, based on high-grade sampling results.
TZ Limited (ASX:TZL) Secures $4M Debt Facility, Finalises Keyvision Acquisition
TZ Limited (ASX:TZL) finalises acquisition of Keyvision Holdings, secures $4M debt facility, and welcomes Keyvision management as strategic shareholders.
Constellation Resources Limited (ASX:CR1) Defines Copper Gold Target at Ularring
Constellation Resources Limited (ASX:CR1) completes a DDIP survey at Ularring, identifying a high-grade copper gold target and announces upcoming drilling plans.
Strickland Metals Limited (ASX:STK) Launches High-Resolution Ground Gravity Survey at Yandal Gold Project
Strickland Metals Limited (ASX:STK) launches a high-resolution gravity survey at Yandal Gold Project and announces an upcoming Mineral Resource update.
New Hope Group (ASX:NHC) Reports H1FY25 Results
New Hope Group (ASX:NHC) reports a 22% increase in EBITDA and declares a 19c interim dividend, highlighting strong H1FY25 performance.
Syntara Limited (ASX:SNT) Expands Skin Scarring Program with SNT-9465
Syntara Limited (ASX:SNT) expands its skin scarring program with the new SNT-9465 drug, initiating Phase 1a/b trials in 2025.